Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 47, 2019 - Issue 1
Submit an article Journal homepage
2,852
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Development of R8 modified epirubicin–dihydroartemisinin liposomes for treatment of non-small-cell lung cancer

Jing-Jing Liua School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, ChinaView further author information
,
Wei Tangb Linyi Food and Drug Testing Center, Linyi, ChinaView further author information
,
Min Fua School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, ChinaView further author information
,
Xiao-Qing Gongc Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology, Beijing, ChinaView further author information
,
Liang Konga School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, ChinaView further author information
,
Xue-Min Yaoa School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, ChinaView further author information
,
Ming Jinga School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, ChinaView further author information
,
Fu-Yi Caia School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, ChinaView further author information
,
Xue-Tao Lia School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, ChinaCorrespondence[email protected]
View further author information
&
Rui-Jun Juc Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology, Beijing, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1947-1960 | Received 04 Apr 2019, Accepted 22 Apr 2019, Published online: 13 May 2019

Citations (33)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (11)

Dehua Kong, Wenyu Hong, Miao Yu, Yanxia Li, YaXin Zheng & Xue Ying. (2022) Multifunctional Targeting Liposomes of Epirubicin Plus Resveratrol Improved Therapeutic Effect on Brain Gliomas. International Journal of Nanomedicine 17, pages 1087-1110.
Read now
Qingrong Li, Qiang Ma, Jibing Cheng, Xi Zhou, Wenjie Pu, Xiaowu Zhong & Xiaolan Guo. (2021) Dihydroartemisinin as a Sensitizing Agent in Cancer Therapies. OncoTargets and Therapy 14, pages 2563-2573.
Read now
Fu-Yi Cai, Xue-Min Yao, Ming Jing, Liang Kong, Jing-Jing Liu, Min Fu, Xin-Ze Liu, Lu Zhang, Si-Yu He, Xue-Tao Li & Rui-Jun Ju. (2021) Enhanced antitumour efficacy of functionalized doxorubicin plus schisandrin B co-delivery liposomes via inhibiting epithelial-mesenchymal transition. Journal of Liposome Research 31:2, pages 113-129.
Read now
Khushwant S. Yadav, Archana Upadhya & Ambikanandan Misra. (2021) Targeted drug therapy in nonsmall cell lung cancer: clinical significance and possible solutions-part II (role of nanocarriers). Expert Opinion on Drug Delivery 18:1, pages 103-118.
Read now
Xiu-ying Li, Luan-xia Shi, Xue-min Yao, Ming Jing, Qin-qing Li, Ying-li Wang & Qing-shan Li. (2021) Functional vinorelbine plus schisandrin B liposomes destroying tumor metastasis in treatment of gastric cancer. Drug Development and Industrial Pharmacy 47:1, pages 100-112.
Read now
Hong-Jun Xie, NorBu Zhan-Dui, Jing Zhao, A. G. A. Er-Bu, Pu Zhen, DongZhi ZhuoMa & Tre Sang. (2021) Evaluation of nanoscaled dual targeting drug-loaded liposomes on inhibiting vasculogenic mimicry channels of brain glioma. Artificial Cells, Nanomedicine, and Biotechnology 49:1, pages 595-604.
Read now
Xiu-ying Li, Jian-hua Wang, Li-yan Gu, Xue-min Yao, Fu-yi Cai, Ming Jing, Xue-tao Li & Rui-jun Ju. (2020) Dual variable of drug loaded micelles in both particle and electrical charge on gastric cancer treatment. Journal of Drug Targeting 28:10, pages 1071-1084.
Read now
Xue-min Yao, Feng-ju Niu, Liang Kong, Fu-yi Cai, Ming Jing, Min Fu, Jing-jing Liu, Si-yu He, Lu Zhang, Xin-ze Liu, Rui-jun Ju & Xue-tao Li. (2020) GGP modified daunorubicin plus dioscin liposomes inhibit breast cancer by suppressing epithelial–mesenchymal transition. Drug Development and Industrial Pharmacy 46:6, pages 916-930.
Read now
Ming Jing, Xiao-Jie Bi, Xue-Min Yao, Fuyi Cai, Jing-Jing Liu, Min Fu, Liang Kong, Xin-Ze Liu, Lu Zhang, Si-Yu He, Lian-Qun Jia & Xue-Tao Li. (2020) Enhanced antitumor efficacy using epirubicin and schisandrin B co-delivery liposomes modified with PFV via inhibiting tumor metastasis. Drug Development and Industrial Pharmacy 46:4, pages 621-634.
Read now
Xiuying Li, Luanxia Shi, Yandong Li, Qinqing Li, Xiujun Duan, Yingli Wang & Qingshan Li. (2020) The enhanced treatment efficacy of invasive brain glioma by dual-targeted artemether plus paclitaxel micelles. Artificial Cells, Nanomedicine, and Biotechnology 48:1, pages 983-996.
Read now
Yun Lu, Qian Wen, Jia Luo, Kang Xiong, ZhouXue Wu, BiQiong Wang, Yue Chen, Bo Yang & ShaoZhi Fu. (2020) Self-assembled dihydroartemisinin nanoparticles as a platform for cervical cancer chemotherapy. Drug Delivery 27:1, pages 876-887.
Read now

Articles from other publishers (22)

Liu‐Gen Li, Xiao‐Xin Yang, Hua‐Zhen Xu, Ting‐Ting Yu, Qi‐Rui Li, Jun Hu, Xing‐Chun Peng, Ning Han, Xiang Xu, Nan‐Nan Chen, Xiao Chen, Jun‐Ming Tang & Tong‐Fei Li. (2023) A Dihydroartemisinin‐Loaded Nanoreactor Motivates Anti‐Cancer Immunotherapy by Synergy‐Induced Ferroptosis to Activate Cgas/STING for Reprogramming of Macrophage. Advanced Healthcare Materials 12:28.
Crossref
Mehrab Pourmadadi, Shima Ostovar, Gustavo Ruiz-Pulido, Dilawar Hassan, Maryam Souri, Amanda-Lee Ezra Manicum, Razieh Behzadmehr, Sonia Fathi-karkan, Abbas Rahdar, Dora I. Medina & Sadanand Pandey. (2023) Novel epirubicin-loaded nanoformulations: Advancements in polymeric nanocarriers for efficient targeted cellular and subcellular anticancer drug delivery. Inorganic Chemistry Communications 155, pages 110999.
Crossref
Chengliang Zhang, Dajiang Song, Lidong Zhang, Lei Liu & Baolin Zhu. (2023) Artemisinin promotes apoptosis of spinal tuberculosis macrophages by inhibiting NF- κ B . Materials Express 13:2, pages 260-266.
Crossref
Dzohara Murillo, Carmen Huergo, Borja Gallego, René Rodríguez & Juan Tornín. (2023) Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer. Biomedicines 11:1, pages 208.
Crossref
Elmira Zolali, Sina Rashedi, Elaheh Dalir Abdolahinia, Nasim Rashedi, Saeideh Allahyari & Nastaran Hashemzadeh. 2023. Principles of Biomaterials Encapsulation : Volume Two. Principles of Biomaterials Encapsulation : Volume Two 589 660 .
Subham Das, Shubham Roy, Seikh Batin Rahaman, Saleem Akbar, Bahar Ahmed, Debojyoti Halder, Anu Kunnath Ramachandran & Alex Joseph. (2022) Structure-Activity Relationship Insight of Naturally Occurring Bioactive Molecules and Their Derivatives Against Non-Small Cell Lung Cancer: A Comprehensive Review. Current Medicinal Chemistry 29:39, pages 6030-6062.
Crossref
Xiao-Xin Yang, Xiang Xu, Mei-Fang Wang, Hua-Zhen Xu, Xing-Chun Peng, Ning Han, Ting-Ting Yu, Liu-Gen Li, Qi-Rui Li, Xiao Chen, Yu Wen & Tong-Fei Li. (2022) A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin. Journal of Nanobiotechnology 20:1.
Crossref
Liu-Gen Li, Xing-Chun Peng, Ting-Ting Yu, Hua-Zhen Xu, Ning Han, Xiao-Xin Yang, Qi-Rui Li, Jun Hu, Bin Liu, Zi-Yi Yang, Xiang Xu, Xiao Chen, Mei-Fang Wang & Tong-Fei Li. (2022) Dihydroartemisinin remodels macrophage into an M1 phenotype via ferroptosis-mediated DNA damage. Frontiers in Pharmacology 13.
Crossref
Ka Hong Wong, Donglin Yang, Shanshan Chen, Chengwei He & Meiwan Chen. (2022) Development of nanoscale drug delivery systems of dihydroartemisinin for cancer therapy: A review. Asian Journal of Pharmaceutical Sciences 17:4, pages 475-490.
Crossref
Xinyu Zhou, Fengzhi Suo, Kristina Haslinger & Wim J. Quax. (2022) Artemisinin-Type Drugs in Tumor Cell Death: Mechanisms, Combination Treatment with Biologics and Nanoparticle Delivery. Pharmaceutics 14:2, pages 395.
Crossref
Xueli Song, Yaping An, Danfeng Chen, Wanru Zhang, Xuemei Wu, Chuqiao Li, Sinan Wang, Wenxiao Dong, Bangmao Wang, Tianyu Liu, Weilong Zhong, Tao Sun & Hailong Cao. (2021) Microbial metabolite deoxycholic acid promotes vasculogenic mimicry formation in intestinal carcinogenesis. Cancer Science 113:2, pages 459-477.
Crossref
Yan Li, Guijie Luan & Ping Guo. (2021) The inhibitory effect of dihydroartemisinin on non-small cells lung cancer. Pharmacological Research - Modern Chinese Medicine 1, pages 100006.
Crossref
Ran Yu, Guihua Jin & Manabu Fujimoto. (2021) Dihydroartemisinin: A Potential Drug for the Treatment of Malignancies and Inflammatory Diseases. Frontiers in Oncology 11.
Crossref
Yanping Li, Xiaoqian Xiao, Huili Wang, Qi Zhou, Zhao Jin, Yuxi Zhang, Yi Wang, Fuping Yue, Shiyi Zhou & Jiahui Yang. (2021) Integrating network pharmacology and experimental models to investigate the mechanisms of dihydroartemisinin in preventing NSCLC progression via mTOR/HIF-1α signaling. European Journal of Pharmacology 909, pages 174411.
Crossref
Saikat Ghosh, Ankit Javia, Saritha Shetty, Denish Bardoliwala, Kuntal Maiti, Shubhadeep Banerjee, Ajay Khopade, Ambikanandan Misra, Krutika Sawant & Subhas Bhowmick. (2021) Triple negative breast cancer and non-small cell lung cancer: Clinical challenges and nano-formulation approaches. Journal of Controlled Release 337, pages 27-58.
Crossref
Ejaj Ahmad, Asgar Ali, Munazza Tamkeen Fatima, Nimisha, Apurva, Arun Kumar, Mamta P. Sumi, Real Sumayya Abdul Sattar, Bhawna Mahajan & Sundeep Singh Saluja. (2021) Ligand decorated biodegradable nanomedicine in the treatment of cancer. Pharmacological Research 167, pages 105544.
Crossref
Salam Massadeh, Iman Almohammed, Eman Barhoush, Mustafa Omer, Nouf Aldhawi, Abdulaziz Almalik & Manal Alaamery. (2021) Development of Epirubicin-Loaded Biocompatible Polymer PLA–PEG–PLA Nanoparticles: Synthesis, Characterization, Stability, and In Vitro Anticancerous Assessment. Polymers 13:8, pages 1212.
Crossref
Xiaoxu Wei, Yunhua Chen, Xianjie Jiang, Miao Peng, Yiduo Liu, Yongzhen Mo, Daixi Ren, Yuze Hua, Boyao Yu, Yujuan Zhou, Qianjin Liao, Hui Wang, Bo Xiang, Ming Zhou, Xiaoling Li, Guiyuan Li, Yong Li, Wei Xiong & Zhaoyang Zeng. (2021) Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Molecular Cancer 20:1.
Crossref
Qingxi Luo, Jun Wang, Wenyuan Zhao, Zhenzi Peng, Xianyu Liu, Bin Li, Heng Zhang, Bin Shan, Chunfang Zhang & Chaojun Duan. (2020) Vasculogenic mimicry in carcinogenesis and clinical applications. Journal of Hematology & Oncology 13:1.
Crossref
Cangcang Xu, Huihui Zhang, Lingli Mu & Xiaoping Yang. (2020) Artemisinins as Anticancer Drugs: Novel Therapeutic Approaches, Molecular Mechanisms, and Clinical Trials. Frontiers in Pharmacology 11.
Crossref
Liang Kong, Fu‐yi Cai, Xue‐min Yao, Ming Jing, Min Fu, Jing‐jing Liu, Si‐yu He, Lu Zhang, Xin‐ze Liu, Rui‐jun Ju & Xue‐tao Li. (2020) RPV‐modified epirubicin and dioscin co‐delivery liposomes suppress non‐small cell lung cancer growth by limiting nutrition supply. Cancer Science 111:2, pages 621-636.
Crossref
Jing Zhang, Xiang Li & Leaf Huang. (2020) Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment. Advanced Drug Delivery Reviews 154-155, pages 245-273.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.